The aetiology of neurological complications of organic acidaemias -: A role for the blood-brain barrier

被引:66
作者
Koelker, S.
Sauer, S. W.
Surtees, R. A. H.
Leonard, J. V.
机构
[1] Inst Child Hlth, Biochem Endocrinol & Metab Unit, London, England
[2] Inst Child Hlth, Dept Neurosci, London, England
[3] Univ Kinderklin Heidelberg, Div Inborn Metab Dis, Dept Gen Paediat, Heidelberg, Germany
关键词
D O I
10.1007/s10545-006-0415-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The blood-brain barrier (BBB) metabolically isolates the central nervous system (CNS) from the circulation and protects it against fluctuations of hydrophilic nutrients in plasma and from intoxication. Recent studies have shown that dicarboxylic acids (DCAs) are transported across the blood-brain barrier at very low rates. In organic acidaemias, neurological complications are common. We hypothesize that, as a result of the very limited efflux, in certain organic acidaemias there is pathological accumulation of DCAs (e.g. glutarate, 3-hydroxyglutarate, D-2- and L-2-hydroxyglutarate, methylmalonate) in the brain secondary to the metabolic block. At high concentrations some of these compounds may become neurotoxic. Treatment should be aimed at preventing the accumulation of these compounds using our understanding of the properties of the BBB.
引用
收藏
页码:701 / 704
页数:4
相关论文
共 31 条
[1]   Sensitivity and specificity of free and total glutaric acid and 3-hydroxyglutaric acid measurements by stable-isotope dilution assays for the diagnosis of glutaric aciduria type I [J].
Baric, I ;
Wagner, L ;
Feyh, P ;
Liesert, M ;
Buckel, W ;
Hoffmann, GF .
JOURNAL OF INHERITED METABOLIC DISEASE, 1999, 22 (08) :867-881
[2]   L-2-HYDROXYGLUTARIC ACIDEMIA - A NOVEL INHERITED NEUROMETABOLIC DISEASE [J].
BARTH, PG ;
HOFFMANN, GF ;
JAEKEN, J ;
LEHNERT, W ;
HANEFELD, F ;
VANGENNIP, AH ;
DURAN, M ;
VALK, J ;
SCHUTGENS, RBH ;
TREFZ, FK ;
REIMANN, G ;
HARTUNG, HP .
ANNALS OF NEUROLOGY, 1992, 32 (01) :66-71
[3]  
Brusilow S., 2001, The Metabolic Molecular Bases of Inherited Disease, V8th ed., P1909
[4]   Glutaryl-CoA dehydrogenase deficiency in Spain:: Evidence of two groups of patients, genetically, and biochemically distinct [J].
Busquets, C ;
Merinero, B ;
Christensen, E ;
Gelpí, JL ;
Campistol, J ;
Pineda, M ;
Fernández-Alvarez, E ;
Prats, JM ;
Sans, A ;
Arteaga, R ;
Martí, M ;
Campos, J ;
Martínez-Pardo, M ;
Martínez-Bermejo, A ;
Ruiz-Falcó, ML ;
Vaquerizo, J ;
Orozco, M ;
Ugarte, M ;
Coll, MJ ;
Ribes, A .
PEDIATRIC RESEARCH, 2000, 48 (03) :315-322
[5]   Neuropathological, biochemical and molecular findings in a glutaric acidemia type 1 cohort [J].
Funk, CBR ;
Prasad, AN ;
Frosk, P ;
Sauer, S ;
Kölker, S ;
Greenberg, CR ;
Del Bigio, MR .
BRAIN, 2005, 128 :711-722
[6]   ARGININOSUCCINIC ACIDURIA - CLINICAL AND BIOCHEMICAL FINDINGS IN 3 CHILDREN WITH THE LATE ONSET FORM, WITH SPECIAL EMPHASIS ON CEREBROSPINAL-FLUID FINDINGS OF AMINO-ACIDS AND PYRIMIDINES [J].
GERRITS, GPJM ;
GABREELS, FJM ;
MONNENS, LAH ;
DEABREU, RA ;
VANRAAIJSELTEN, B ;
NIEZENKONING, KE ;
TRIJBELS, JMF .
NEUROPEDIATRICS, 1993, 24 (01) :15-18
[7]  
GOODMAN SI, 1977, J PEDIATR-US, V90, P746, DOI 10.1016/S0022-3476(77)81240-7
[8]   Cerebral dicarboxylate transport and metabolism studied with isotopically labelled fumarate, malate and malonate [J].
Hassel, B ;
Bråthe, A ;
Petersen, D .
JOURNAL OF NEUROCHEMISTRY, 2002, 82 (02) :410-419
[9]   PHYSIOLOGY AND PATHOPHYSIOLOGY OF ORGANIC-ACIDS IN CEREBROSPINAL-FLUID [J].
HOFFMANN, GF ;
MEIERAUGENSTEIN, W ;
STOCKLER, S ;
SURTEES, R ;
RATING, D ;
NYHAN, WL .
JOURNAL OF INHERITED METABOLIC DISEASE, 1993, 16 (04) :648-669
[10]   Clinical course, early diagnosis, treatment, and prevention of disease in glutaryl-CoA dehydrogenase deficiency [J].
Hoffmann, GF ;
Athanassopoulos, S ;
Burlina, AB ;
Duran, M ;
deKlerk, JBC ;
Lehnert, W ;
Leonard, JV ;
Monavari, AA ;
Muller, E ;
Muntau, AC ;
Naughten, ER ;
PleckoStarting, B ;
SupertiFurga, A ;
Zschocke, J ;
Christensen, E .
NEUROPEDIATRICS, 1996, 27 (03) :115-123